Home
Gujarat Themis Biosyn Ltd Share Price History
Gujarat Themis Biosyn Ltd
BSE : 21 Feb, 2025
244.4-0.1 (-0.0%)
Prev Close
244.4
Open Price
244.4
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
41355
Today's High / Low
253.4 / 242.0
52 WK High / Low
390.0 / 192.4
Market Price of Gujarat Themis Biosyn Ltd
1M
1Y
3Y
5Y
Monitoring Gujarat Themis Biosyn Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 36 |
| Sales YoY Gr. | - |
| Adj EPS | 3.01 |
| YoY Gr. | - |
| Net Profit (Cr.) | 4 |
| BVPS | 5.65 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 38.55 |
| Op. Profit Mgn % | 17.96 |
| Net Profit Mgn % | 12.27 |
| Debt to Equity % | 0.61 |
Latest Shareholding
Promoters Holdings Over Time
About Gujarat Themis Biosyn Ltd
- Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
- It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.
Popular Search
FAQs for Gujarat Themis Biosyn Ltd Share Price History
What are the key events that typically impact Gujarat Themis Biosyn Ltd's share price history?
Key events that impact Gujarat Themis Biosyn Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Gujarat Themis Biosyn Ltd's share price history?
Stock splits reduce the nominal price of Gujarat Themis Biosyn Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Gujarat Themis Biosyn Ltd?
Dividends can influence Gujarat Themis Biosyn Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Gujarat Themis Biosyn Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Gujarat Themis Biosyn Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Gujarat Themis Biosyn Ltd’s share price history?
To understand Gujarat Themis Biosyn Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
